Royalty Pharma plc (NASDAQ:RPRX) Receives $52.50 Consensus PT from Analysts

Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has been given a consensus rating of “Buy” by the four ratings firms that are presently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a buy rating. The average 12 month price target among analysts that have covered the stock in the […]

Related Keywords

United States ,Georgew Lloyd , ,Nasdaq ,Sageworth Trust Co ,International Assets Investment Management ,Securities Exchange Commission ,Royalty Pharma Company Profile ,Royalty Pharma ,Get Free Report ,Exchange Commission ,Forest Capital Management ,Financial Advisors ,Get Free ,Royalty Pharma Daily ,Nasdaq Rprx ,Rprx ,Finance ,76028h20 ,Ratings ,Consensus ,